Literature DB >> 18636671

Mechanisms underlying aspirin-mediated growth inhibition and apoptosis induction of cyclooxygenase-2 negative colon cancer cell line SW480.

Ming-Yu Lai1, Jie-An Huang, Zhi-Hai Liang, Hai-Xing Jiang, Guo-Du Tang.   

Abstract

AIM: To investigate the effects of aspirin (acetylsalicylic acid) on proliferation and apoptosis of colorectal cancer cell line SW480 and its mechanism.
METHODS: Cyclooxygenase (COX)-2 negative colorectal cancer cell line SW480 was treated with aspirin at concentrations of 2.5 mmol/L, 5.0 mmol/L, 10.0 mmol/L for different periods in vitro. Anti-proliferation effect of aspirin on SW480 was detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cell cycle and apoptosis were observed by flow cytometry (FCM). Transmission electron microscope (TEM) was used for morphological study. Apoptosis-associated genes were detected by immunohistochemical staining and Western blotting.
RESULTS: Aspirin inhibited SW480 proliferation and induced apoptosis in a dose- and time-dependent manner. Treatment with different concentrations of aspirin significantly increased the proportions of cells at the G(0)/G(1)phase and decreased the proportions of cells at the S- and G(2)/M phases in a concentration-dependent manner. Aspirin not only induced apoptosis but also caused cell necrosis at a high concentration as well. After treatment with aspirin, SW480 cells displayed typically morphological features of apoptosis and necrosis under TEM, and increased the Bcl-2 expression in cells, but the expression of Bax was down regulated.
CONCLUSION: Aspirin inhibits proliferation and induces apoptosis of SW480 cells. Its anti-tumor mechanism may arrest cell cycle and shift Bax/Bcl-2 balance in cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636671      PMCID: PMC2725387          DOI: 10.3748/wjg.14.4227

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

Review 1.  Chemoprevention of colorectal cancer.

Authors:  P A Jänne; R J Mayer
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

2.  Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.

Authors:  A J Marrogi; W D Travis; J A Welsh; M A Khan; H Rahim; H Tazelaar; P Pairolero; V Trastek; J Jett; N E Caporaso; L A Liotta; C C Harris
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

3.  Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.

Authors:  M Richter; M Weiss; I Weinberger; G Fürstenberger; B Marian
Journal:  Carcinogenesis       Date:  2001-01       Impact factor: 4.944

4.  Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study.

Authors:  L A García Rodríguez; C Huerta-Alvarez
Journal:  Epidemiology       Date:  2000-07       Impact factor: 4.822

5.  The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.

Authors:  M L Smith; G Hawcroft; M A Hull
Journal:  Eur J Cancer       Date:  2000-03       Impact factor: 9.162

6.  Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.

Authors:  L A García-Rodríguez; C Huerta-Alvarez
Journal:  Epidemiology       Date:  2001-01       Impact factor: 4.822

7.  Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex.

Authors:  S M Plummer; K A Holloway; M M Manson; R J Munks; A Kaptein; S Farrow; L Howells
Journal:  Oncogene       Date:  1999-10-28       Impact factor: 9.867

8.  Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin.

Authors:  W J Thompson; G A Piazza; H Li; L Liu; J Fetter; B Zhu; G Sperl; D Ahnen; R Pamukcu
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

9.  Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells.

Authors:  R A Sharma; A Gescher; J P Plastaras; C Leuratti; R Singh; B Gallacher-Horley; E Offord; L J Marnett; W P Steward; S M Plummer
Journal:  Carcinogenesis       Date:  2001-09       Impact factor: 4.944

10.  Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts.

Authors:  X Zhang; S G Morham; R Langenbach; D A Young
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

View more
  11 in total

1.  Inflammation and colorectal cancer: does aspirin affect the interaction between cancer and immune cells?

Authors:  Michael Bergman; Meir Djaldetti; Hertzel Salman; Hanna Bessler
Journal:  Inflammation       Date:  2011-02       Impact factor: 4.092

2.  Cyclooxygenase (COX) Inhibition by Acetyl Salicylic Acid (ASA) Enhances Antitumor Effects of Nitric Oxide in Glioblastoma In Vitro.

Authors:  Jessica Guenzle; Nicklas W C Garrelfs; Jonathan M Goeldner; Astrid Weyerbrock
Journal:  Mol Neurobiol       Date:  2019-02-04       Impact factor: 5.590

3.  Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC.

Authors:  Annachiara Mitrugno; Joanna L Sylman; Anh T P Ngo; Jiaqing Pang; Rosalie C Sears; Craig D Williams; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2016-11-30       Impact factor: 4.249

4.  SOX7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells.

Authors:  Xin Zhou; Shu-Yan Huang; Jing-Xin Feng; Yan-Yan Gao; Li Zhao; Jun Lu; Bai-Qu Huang; Yu Zhang
Journal:  World J Gastroenterol       Date:  2011-11-28       Impact factor: 5.742

5.  TGF-β1 mediates the effects of aspirin on colonic tumor cell proliferation and apoptosis.

Authors:  Yuyi Wang; Chi Du; Nan Zhang; Mei Li; Yanyang Liu; Maoyuan Zhao; Feng Wang; Feng Luo
Journal:  Oncol Lett       Date:  2018-02-14       Impact factor: 2.967

6.  Efficacy of acetylsalicylic acid (aspirin) in skin B16-F0 melanoma tumor-bearing C57BL/6 mice.

Authors:  Nikhil M Vad; Shashi K Kudugunti; Hezhen Wang; G Jayarama Bhat; Majid Y Moridani
Journal:  Tumour Biol       Date:  2014-02-04

Review 7.  Modulators affecting the immune dialogue between human immune and colon cancer cells.

Authors:  Meir Djaldetti; Hanna Bessler
Journal:  World J Gastrointest Oncol       Date:  2014-05-15

Review 8.  NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates.

Authors:  Yoshihiro Suzuki; Toshio Inoue; Chisei Ra
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-19

9.  Design, synthesis and biological evaluation of hybrids of β-carboline and salicylic acid as potential anticancer and apoptosis inducing agents.

Authors:  Qi-Bing Xu; Xiang-Fan Chen; Jiao Feng; Jie-Fei Miao; Ji Liu; Feng-Tao Liu; Bi-Xi Niu; Jin-Yang Cai; Chao Huang; Yanan Zhang; Yong Ling
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

10.  Antagonism between salicylate and the cAMP signal controls yeast cell survival and growth recovery from quiescence.

Authors:  Maurizio D Baroni; Sonia Colombo; Enzo Martegani
Journal:  Microb Cell       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.